Literature DB >> 15639772

Distinguishing bipolar depression, major depression, and schizophrenia with the MMPI-2 clinical and content scales.

R Michael Bagby1, Margarita B Marshall, Michael R Basso, Robert A Nicholson, Jason Bacchiochi, Lesley S Miller.   

Abstract

Clinical and content scales from the MMPI-2 (Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer, 1989) were used to examine the capacity of these scales to assist in the differential diagnosis of a sample of 212 psychiatric patients-137 with major depression; 43 with schizophrenia; and 32 with bipolar disorder, depressed state. Consistent with the previous literature, the clinical scales Depression (D), and Schizophrenia (Sc), and the content scales Depression (DEP), and Low Self-Esteem (LSE) best distinguished major depression from schizophrenia; the content scale DEP proved to be the most powerful predictor in distinguishing bipolar depression from schizophrenia. No clinical or content scale proved to be effective in distinguishing patients with bipolar depression from patients with major depression. In general, the content scales outperformed the clinical scales.

Entities:  

Mesh:

Year:  2005        PMID: 15639772     DOI: 10.1207/s15327752jpa8401_15

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  3 in total

1.  Use of the MMPI-2 personality profile in predicting 30-day ED-visits and readmissions following primary bariatric surgery.

Authors:  Jennwood Chen; Anahita Jalilvand; Mahmoud Abdel-Rasoul; Kayla Diaz; Lindsay Breslin; Vivian L Wang; Bradley Needleman; Sabrena F Noria
Journal:  Surg Endosc       Date:  2020-09-02       Impact factor: 4.584

2.  A study of remitted and treatment-resistant depression using MMPI and including pessimism and optimism scales.

Authors:  Masatoshi Suzuki; Michio Takahashi; Katsumasa Muneoka; Koichi Sato; Kenji Hashimoto; Yukihiko Shirayama
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

3.  Understanding MMPI-2 response structure between schizophrenia and healthy individuals.

Authors:  Yu Cheng Hsu; Zhiyu Ye; Lisha Dai; Yaqin Jing; Kwok-Leung Tsui; Paul S F Yip; Wentian Li; Qingpeng Zhang
Journal:  Front Psychiatry       Date:  2022-07-28       Impact factor: 5.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.